Bioxyne Limited (AU:BXN) has released an update.
Bioxyne Limited has confirmed compliance with all relevant ASX Listing Rules, following a price query from the ASX regarding recent trading activity of its securities. The company has disclosed no unannounced information that might explain the trading activity, noting their recent market-sensitive announcement about the successful production of Australia’s first pharmaceutical cannabis gummies under a GMP Licence.
For further insights into AU:BXN stock, check out TipRanks’ Stock Analysis page.